Effects of Zoledronic Acid on Craniofacial Structure in Osteogenesis Imperfecta Mice
Author Information
Author(s): Jeannerod Gaspard, Chretien Antoine, André Grégoire, Mabilleau Guillaume, Behets Catherine
Primary Institution: UCLouvain
Hypothesis
Does zoledronic acid improve craniofacial structure in osteogenesis imperfecta mice?
Conclusion
Zoledronic acid has beneficial effects on craniofacial vertical height and ramus density in osteogenesis imperfecta mice.
Supporting Evidence
- ZA-treated mice showed increased mandibular length and incisor height compared to untreated mice.
- Total mineral density and cortical mineral density were significantly higher in the mandibular ramus of the ZA group.
- A significant positive correlation was found between mandibular height and cortical mineral density.
Takeaway
This study looked at how a medicine called zoledronic acid helps the faces of mice with a bone disease called osteogenesis imperfecta grow better.
Methodology
Thirty female osteogenesis imperfecta mice were divided into two groups: one received zoledronic acid and the other was untreated. Various measurements were taken before and after treatment.
Limitations
The study had a small sample size and some results were at the limit of significance.
Participant Demographics
Thirty homozygous female osteogenesis imperfecta mice.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website